Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Our Swindon facility specializes in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency products and LVP.
The Swindon facility offers extensive development and commercial capabilities for sterile dosage forms, including:
Additionally, the facility has extensive complex technology transfer expertise. It employs Qualified Persons (QPs) to ensure prompt release of bulk products within the European market and has received regulatory approval from various international regulatory inspection agencies, including: MHRA, FDA and the Gulf Co-operation Council.
Learn about the specific equipment and unique capabilities at this site by downloading our Site Fact Sheet.